FOXP3 and neoplasm: Meanwhile, administration of low-dose TSA in tumor-bearing mice did not result in significant changes in the frequency of Foxp3+ Treg cells in TILs, spleen and blood in tumor-bearing mice (Supplementary Fig. 4c).